|
KMID : 0620920180500020003
|
|
Experimental & Molecular Medicine
2018 Volume.50 No. 2 p.3 ~ p.3
|
|
|
Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
|
|
Vela Driton
Vela-Gaxha Zana
|
|
|
Abstract
|
|
|
|
Hepcidin is a crucial peptide for regulating cellular iron efflux. Because iron is essential for cell survival, especially for highly active cells, such as tumor cells, it is imperative to understand how tumor cells manipulate hepcidin expression for their own metabolic needs. Studies suggest that hepcidin expression and regulation in tumor cells show important differences in comparison with those in non-tumorous cells. These differences should be investigated to develop new strategies to fight cancer cells. Manipulating hepcidin expression to starve cancer cells for iron may prove to be a new therapy in the anticancer arsenal.
|
|
|
KEYWORD
|
|
|
Cancer microenvironment, Prognostic markers
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
    
|